@misc{indiciae567e730494ed,
  title = {Valuing Post-Revenue Biopharmaceutical Assets with Pfizer's Current Portfolio as a Case Study},
  author = {Yongzhuo Chen and Yixuan Liang and Yiran Liu and Brian Hobbs and Michael Kane},
  year = {2023},
  url = {https://arxiv.org/abs/2312.02250},
  note = {Source identifier: 2312.02250}
}